Zoetis Inc. (ZTS) is a renowned global leader in the animal health industry. Incorporated in 1952 and headquartered in Parsippany, New Jersey, United States, the company has a prominent presence around the globe, offering its products and services in approximately 100 countries.
Zoetis is committed to innovating and serving veterinarians, livestock producers, pet owners, and other animal health professionals. The company's comprehensive portfolio comprises over 300 product lines, covering eight core animal species, including dogs, cats, horses, cattle, swine, poultry, sheep, and fish. Zoetis is known for developing, manufacturing, and commercializing an impressive range of veterinary medicines, vaccines, diagnostic products, genetic tests, biodevices, and a variety of services.
The portfolio includes popular products like Apoquel and Cytopoint for treating allergic dermatitis in dogs, and Draxxin, a leading antibiotic for livestock. Additionally, Zoetis has launched innovative diagnostic products like the WITNESS line of rapid diagnostic tests and ClariFly, a feed supplement to prevent flies in livestock environments.
Zoetis is committed to advancing animal health and well-being worldwide. They continually invest in research and development in anticipation of the evolving needs of animal health. This unrelenting focus on innovation and cutting-edge technology has positioned Zoetis as a frontrunner in their field, enabling them to provide valuable solutions to the widest possible community of customers.
In the financial perspective, Zoetis has been consistently delivering strong performance. The company has been listed on the New York Stock Exchange (NYSE) since 2013 under the ticket name "ZTS". It has progressively grown its shareholder returns, thanks to its robust financials and future-oriented strategy.
Moreover, the company's commitment to corporate responsibility is commendable. Zoetis takes a holistic approach in its operations, taking into account environmental preservation, animal well-being, employee safety, product quality, and corporate governance.
Overall, Zoetis has a rich heritage and a bright future in global animal health, standing as a pillar of industry expertise and customer service. With the drive for continuous growth and commitment to breaking new grounds in animal health, Zoetis is set for remarkable innovations and breakthroughs in the field.